Clin2
NCT06129253Worth exploringRecruiting

GLOBE-HPV: Study of HPV in communities

HPV Infection

Treatments studied

Part of Cancer, Infections, Women’s health & pregnancy clinical trials.

This study is trying to find out how many people in different communities have HPV (human papillomavirus). It involves collecting samples and answering questions to help estimate the global burden of HPV.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
29,750 people
Ages
9 years to 50 years
Study type
Observational

Who can take part

  • You are between 9 and 50 years old.
  • You have lived in the community for at least 3 months (or you are a pastoralist, refugee, or commercial sex worker).
  • You can understand what the study is about and what you will need to do.
  • If you are 18 or older, you can give your own permission. If you are under 18, a parent or guardian can give permission and you agree to take part.
  • You do not have a medical condition (unrelated to HPV) that the study doctor thinks would make it unsafe for you to join.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07428330Recruiting
HPV self-testing to improve cervical cancer screening for women with HIV

This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.

Kampala
NCT07336134Recruiting
HPV self-test for cervical health

This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.

Philadelphia, Pennsylvania
NCT05262010Recruiting· Phase 3
HPV vaccine study for Chinese women, ages 9–45

This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.

Hechi, Guangxi
NCT07733557Not yet recruiting
HPV detection from self-collected menstrual blood

This study is testing whether menstrual blood you collect at home can be used to detect HPV (the virus linked to cervical cancer). If you're due for an HPV test or recently had one, you may be able to participate by providing a menstrual sample instead of a traditional clinic swab.

Charlottesville, Virginia
NCT07281430Recruiting
HPV self-test for cervical cancer screening

This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.

Birmingham, Alabama
NCT05528237Enrolling by invitation
HPV self-test to help cervical cancer screening access

This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.

Seattle, Washington

Hear when a new HPV Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.